0A4F4F9BD490A749D5437F821CF06DF1
Statements by the Commission Re: Article 6 (2006)
https://www.uv.es/operuv/docs_7pm/FP7ECStatementsComm_Ethical.pdf
http://leaux.net/URLS/ConvertAPI Text Files/6D4D40D0DCD15E59CED39507DEE3A1D4.en.txt
Examining the file media/Synopses/6D4D40D0DCD15E59CED39507DEE3A1D4.html:
This file was generated: 2020-07-15 06:47:16
| Indicators in focus are typically shown highlighted in yellow; |
Peer Indicators (that share the same Vulnerability association) are shown highlighted in pink; |
"Outside" Indicators (those that do NOT share the same Vulnerability association) are shown highlighted in green; |
Trigger Words/Phrases are shown highlighted in gray. |
Link to Orphaned Trigger Words (Appendix (Indicator List, Indicator Peers, Trigger Words, Type/Vulnerability/Indicator Overlay)
Applicable Type / Vulnerability / Indicator Overlay for this Input
Health / stem cells
Searching for indicator stem cells:
(return to top)
p.(None): deciding on the EU funding of human embryonic stem cell research as in the 6th Framework Programme.
p.(None):
p.(None): The European Commission proposes the continuation of this ethical framework because it has developed,
p.(None): based on experience, a responsible approach for an area of science which holds much promise and that has proven to work
p.(None): satisfactorily in the context of a research programme in which researchers participate from many countries with very
p.(None): diverse regulatory situations.
p.(None):
p.(None): (1) The decision on the 7th Framework Programme explicitly excludes three fields of research from Com- munity
p.(None): funding:
p.(None): — research activities aiming at human cloning for reproductive purposes;
p.(None):
p.(None): — research activities intended to modify the genetic heritage of human beings which could make such changes heritable;
p.(None):
p.(None): — research activities intended to create human embryos solely for the purpose of research or for the purpose of stem
p.(None): cell procurement, including by means of somatic cell nuclear transfer.
p.(None):
p.(None): (2) No activity will be funded that is forbidden in all Member States. No activity will be funded
p.(None): in a Member State where such activity is forbidden.
p.(None):
p.(None): (3) The decision on FP7 and the provisions for the ethical framework governing the Community funding of human
p.(None): embryonic stem cell research entail in no way a value judgement on the regulatory or ethical framework governing such
p.(None): research in Member States.
p.(None):
p.(None): (4) In calling for proposals, the European Commission does not explicitly solicit the use of human
p.(None): embryonic stem cells. The use of human stem cells, be they adult or embryonic, if any, depends on the judgement of the
p.(None): scientists in view of the objectives they want to achieve. In practice, by far the largest part of Community funds for
p.(None): stem cell research is devoted to the use of adult stem cells. There is no reason why this would substantially change in
p.(None): FP7.
p.(None):
p.(None): (5) Each project proposing to use human embryonic stem cells must successfully pass a scientific evalua- tion during
p.(None): which the necessity of using such stem cells to achieve the scientific objectives is assessed by independent scientific
p.(None): experts.
p.(None):
p.(None): (6) Proposals which successfully pass the scientific evaluation are then subject to a stringent ethical review
p.(None): organised by the European Commission. In this ethical review, account is taken of principles reflected in the EU
p.(None): Charter of Fundamental Rights and relevant international conventions such as the Conven- tion of the Council of Europe
p.(None): on Human Rights and Biomedicine signed in Oviedo on 4 April 1997 and its additional protocols and the Universal
p.(None): Declaration on the Human Genome and the Human Rights adopted by UNESCO. The ethical review also serves
p.(None): to check that the proposals respect the rules of the countries where the research will be carried out.
p.(None):
p.(None): (7) In particular cases, an ethical review may be carried out during the lifetime of the project.
p.(None):
p.(None): (8) Each project proposing to use human embryonic stem cells must seek the approval of the relevant
p.(None): national or local ethics committee prior to the start of the project. All national rules and procedures must be
p.(None): respected, including on such issues as parental consent, absence of financial inducement, etc. Checks will be made on
p.(None): whether the project includes references to licensing and control measures to be taken by the competent authorities of
p.(None): the Member State where the research will be carried out.
p.(None):
p.(None): (9) A proposal that successfully passes the scientific evaluation, the national or local ethical
p.(None): reviews and the European ethical review will be presented for approval, on a case by case basis, to
p.(None): the Member States, meeting as a Regulatory Committee. No project involving the use of human embryonic
p.(None): stem cells will be funded that does not obtain approval from the Member States.
p.(None):
p.(None): 30.12.2006 EN
p.(None): Official Journal of the European Union
p.(None): L 412/43
p.(None):
p.(None): (10) The European Commission will continue to work to make the results from Community funded stem cell research widely
p.(None): accessible to all researchers, for the ultimate benefit of patients in all countries.
p.(None): (11) The European Commission will support actions and initiatives that contribute to a coordination and
p.(None): rationalisation of HESC research within a responsible ethical approach. In particular, the Commission will support a
p.(None): European registry of human embryonic stem cell lines. Support for such a registry will allow a monitoring of
p.(None): existing human embryonic stem cells in Europe, will contribute to maximise their use by scientists and may
p.(None): help to avoid unnecessary derivations of new stem cell lines.
p.(None): (12) The European Commission will continue with the current practice and will not submit to the Regula- tory Committee
p.(None): proposals for projects which include research activities which destroy human embryos, including for the procurement of
p.(None): stem cells. The exclusion of funding of this step of research will not prevent Community funding of subsequent steps
p.(None): involving human embryonic stem cells.
p.(None):
p.(None): Re the Energy theme
p.(None): The ten themes of the Cooperation Programme include research needed to underpin the formulation, imple- mentation and
p.(None): assessment of Community policies to which the Commission attaches a central role. It appreciates the
p.(None): importance that the European Parliament attaches to energy policy in general and to the promotion of
p.(None): energy efficiency and renewable energy sources in particular. In order to allow the Parliament to follow the
p.(None): implementation of the Programme, the Commission intends to continue the policy of transpar- ency and provision of
p.(None): information. Appropriate information on projects funded by the FP will be fully avail- able to the public through
p.(None): the internet. Particular attention will be given to ensuring, at least every two years, a comprehensive
p.(None): presentation of projects related to rational and efficient use of energy and the role of renewable energy sources.
p.(None):
p.(None): Re Ideas
p.(None): In the context of the progress report referred to in Article 7(2) and preceding the interim evaluation,
p.(None): the Commission will present to the European Parliament and the Council by mid-2008 a Communication on the
p.(None): methodology and terms of reference to be used for the review to be carried out by independent experts concerning the
p.(None): ERC's structures and mechanisms. If necessary the Commission will present a proposal for the adaptation of the
...
Social / genetic heritage
Searching for indicator genetic heritage:
(return to top)
p.(None): L 412/42 EN
p.(None): Official Journal of the European Union
p.(None): 30.12.2006
p.(None):
p.(None): STATEMENTS BY THE COMMISSION
p.(None):
p.(None): Re Article 6
p.(None):
p.(None): For the 7th Framework Programme, the European Commission proposes to continue with the same ethical framework for
p.(None): deciding on the EU funding of human embryonic stem cell research as in the 6th Framework Programme.
p.(None):
p.(None): The European Commission proposes the continuation of this ethical framework because it has developed,
p.(None): based on experience, a responsible approach for an area of science which holds much promise and that has proven to work
p.(None): satisfactorily in the context of a research programme in which researchers participate from many countries with very
p.(None): diverse regulatory situations.
p.(None):
p.(None): (1) The decision on the 7th Framework Programme explicitly excludes three fields of research from Com- munity
p.(None): funding:
p.(None): — research activities aiming at human cloning for reproductive purposes;
p.(None):
p.(None): — research activities intended to modify the genetic heritage of human beings which could make such changes heritable;
p.(None):
p.(None): — research activities intended to create human embryos solely for the purpose of research or for the purpose of stem
p.(None): cell procurement, including by means of somatic cell nuclear transfer.
p.(None):
p.(None): (2) No activity will be funded that is forbidden in all Member States. No activity will be funded
p.(None): in a Member State where such activity is forbidden.
p.(None):
p.(None): (3) The decision on FP7 and the provisions for the ethical framework governing the Community funding of human
p.(None): embryonic stem cell research entail in no way a value judgement on the regulatory or ethical framework governing such
p.(None): research in Member States.
p.(None):
p.(None): (4) In calling for proposals, the European Commission does not explicitly solicit the use of human
p.(None): embryonic stem cells. The use of human stem cells, be they adult or embryonic, if any, depends on the judgement of the
p.(None): scientists in view of the objectives they want to achieve. In practice, by far the largest part of Community funds for
p.(None): stem cell research is devoted to the use of adult stem cells. There is no reason why this would substantially change in
p.(None): FP7.
p.(None):
p.(None): (5) Each project proposing to use human embryonic stem cells must successfully pass a scientific evalua- tion during
p.(None): which the necessity of using such stem cells to achieve the scientific objectives is assessed by independent scientific
p.(None): experts.
p.(None):
...
Orphaned Trigger Words
Appendix
Indicator List
| Indicator | Vulnerability |
|---|
| genetic heritage | genetic heritage |
| stem cells | stem cells |
Indicator Peers (Indicators in Same Vulnerability)
Trigger Words
consent
ethics
Applicable Type / Vulnerability / Indicator Overlay for this Input